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What is already known about the topic?
•• Advance care planning (ACP) has proved its effectiveness in trials and has been widely used and promoted in Western 
countries.
•• No systematic reviews focusing on the conceptual model and mechanisms of action of ACP have been critically appraised.
The conceptual models and mechanisms of 
action that underpin advance care planning 
for cancer patients: A systematic review of 
randomised controlled trials
Cheng-Pei Lin1 , Catherine J Evans1,2, Jonathan Koffman1, Jo Armes3,  
Fliss E M Murtagh1,4 and Richard Harding1
Abstract
Background: No systematic review has focused on conceptual models underpinning advance care planning for patients with advanced 
cancer, and the mechanisms of action in relation to the intended outcomes.
Aim: To appraise conceptual models and develop a logic model of advance care planning for advanced cancer patients, examining the 
components, processes, theoretical underpinning, mechanisms of action and linkage with intended outcomes.
Design: A systematic review of randomised controlled trials was conducted, and was prospectively registered on PROSPERO. Narrative 
synthesis was used for data analysis.
Data sources: The data sources were MEDLINE, CINAHL, PsycINFO, EMBASE, CENTRAL, PROSPERO, CareSearch, and OpenGrey 
with reference chaining and hand-searching from inception to 31 March 2017, including all randomised controlled trials with 
advance care planning for cancer patients in the last 12 months of life. Cochrane quality assessment tool was used for quality 
appraisal.
Results: Nine randomised controlled trials were included, with only four articulated conceptual models. Mechanisms through which 
advance care planning improved outcomes comprised (1) increasing patients’ knowledge of end-of-life care, (2) strengthening 
patients’ autonomous motivation, (3) building patients’ competence to undertake end-of-life discussions and (4) enhancing shared 
decision-making in a trustful relationship. Samples were largely highly educated Caucasian.
Conclusion: The use of conceptual models underpinning the development of advance care planning is uncommon. When used, they 
identify the individual behavioural change. Strengthening patients’ motivation and competence in participating advance care planning 
discussions are key mechanisms of change. Understanding cultural feasibility of the logic model for different educational levels and 
ethnicities in non-Western countries should be a research priority.
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What this paper adds?
•• A novel logic model of ACP for advanced cancer patients drawn from Western studies was constructed. No non-Western 
studies and models were discovered.
•• It is uncommon to apply conceptual models to underpin the development of ACP, while anticipated individual behaviour 
change was mainly identified in trials.
•• Key mechanisms of action focused on facilitating patient’s knowledge and building up motivation and competence in par-
ticipating ACP, leading to making a decision within a trustful clinician–patient relationship.
Implications for practice, theory or policy
•• This logic model cannot be currently transferred as theory as it is mainly Western oriented. This presents an obstacle to 
good care globally.
•• There is an urgent need to explore the applicability of this Western-oriented logic model for different educational levels 
and diverse ethnicities in non-Western countries to meet the Universal Health Coverage palliative care goal.
Background
There has been increasing awareness of the importance 
of enabling a person’s autonomous decision-making at 
the end of life. Attainment of preferences, such as place of 
death, is considered an indicator of high-quality end-of-
life care.1 However, patients’ end-of-life preferences 
such as preferences for life-sustaining treatments, artifi-
cial nutrition and hydration, and place of death are not 
routinely discussed prior to patients’ loss of capacity to 
make the decision for themselves.2 This may negatively 
impact quality of life as the individual might not be cared 
for in a way they would have chosen, which in turn may 
increase levels of stress, anxiety and depression for their 
families.3,4
Several written documents were introduced and pro-
moted in the late 1960s as a tool to maintain a person’s 
autonomy about their end-of-life care (e.g. Advance 
Directives, Living Wills).5 However, evaluations of these 
focused largely on the completion rate of these written 
documents, thus failing to understand the achievement of 
a person’s values, goals and preferences for end-of-life 
care and the impact on their quality of life.5–9 The docu-
mentation also poorly specified a person’s preferences 
and did not recognise that availability of health resources 
may differ from the hypothetical situation detailed in an 
advance directive.10 These challenges led in the 1990s to 
the development of a conceptual alternative – Advance 
Care Planning (ACP).11 ACP was considered more appro-
priate in ensuring patients’ access to preferred care, by 
conducting a mutual communication between patients, 
families and healthcare professionals to achieve consen-
sus on future care. Evidence suggests that ACP benefit 
patients (e.g. quality of life, compliance with wishes), 
their family (e.g. satisfaction with care, emotional dis-
tress, bereavement), the healthcare system (e.g. cost, 
hospitalisation rate) and increases completion 
rates.4,8,10,12,13 At present, the practice of ACP is more 
common in mainly the Western countries such as 
Australia,14 United Kingdom15 and North America.16
Careful consideration of cultural appropriateness, 
context and adaptation is absolutely critical to enhance 
uptake in other parts of the world.17,18 A systematic 
review highlighted that the standard ACP failed to cap-
ture patient’s preferences across cultures.19 This empha-
sises the importance of investigating the intervention’s 
suitability and developing a culturally sensitive ACP 
before adopting it.20 Moreover, a better understanding 
of the underpinning conceptual models (defined as a 
guide to understand the interactions between imple-
mentation processes and the systems in which the 
intervention is implemented21) and mechanisms of 
action (defined as a comprehensive description of how 
and why a desire change is expected to happen in a cer-
tain context21) is required to ensure the cultural appro-
priateness and potential effectiveness of ACP. This is 
imperative prior to it being tested and implemented.22,21 
No review to our knowledge has specifically focused on 
conceptual models that underpin ACP for advanced can-
cer patients, nor critically considered the process of 
delivery and mechanisms of action in relation to the 
intended outcomes.
To address this, we conducted a systematic review 
that aimed to identify and appraise the conceptual mod-
els underpinning ACP interventions and the components 
of implementing ACP, identifying the outcomes meas-
ured and tools used, and how the outcomes are achieved 
(mechanisms of action) in order to develop an evidence-
based logic model (defined as a diagram showing how a 
programme influences its participants to achieve 
intended outcomes or sustainable change21). A logic 
model can be used to describe the resources needed to 
operate the programme, and to communicate the pro-
gramme design to potential stakeholders for developing 
theoretically plausible and acceptable ACP interventions 
for advanced cancer patients.21
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Methods
Study design
A systematic literature review drew on Cochrane 
guidance23, Guidance on the Conduct of Narrative 
Synthesis in Systematic Reviews,24 and Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis (PRISMA) 
guidance25 for reporting systematic reviews. Previous sys-
tematic reviews on ACP 4,7,9,10,12,13 were used to inform the 
search strategy.
Protocol and registration
The systematic review protocol was prospectively reg-
istered on PROSPERO26 (CRD42017067628; http://www 
.crd.york.ac.uk/PROSPERO/display_record.php? 
ID = CRD42017067628).
Databases and search strategy
We searched eight electronic databases (MEDLINE, 
CINAHL, PsycINFO, EMBASE, Cochrane Register of 
Controlled Trials (CENTRAL), York Centre (PROSPERO), 
CareSearch, OpenGrey from inception to 31 March 2017. 
The PICOS framework27 was applied to the study aim to 
inform the search terms, drawing on previous systematic 
reviews on ACP4,9,10 to refine the search strategy (see 
Table S1). Medical subject headings were used for explor-
ing synonyms and Boolean operators ‘AND’ and ‘OR’ were 
applied (see Figure S1). In addition, we hand-searched key 
journals (Journal of Palliative Care, Journal of Palliative 
Medicine, Psycho-Oncology, BMJ Supportive and Palliative 
Care, BMC Palliative Care, Journal of Clinical Oncology) to 
perform a comprehensive search.28
Inclusion and exclusion criteria
ACP is defined as a process that supports adults at any age 
or stage of health in understanding and sharing their per-
sonal values, life goals and preferences regarding future 
medical care.29 It includes written documents or any type 
of record to reflect a patient’s values, goals, preferences 
and aspirations (e.g. Advance Statement) and/or a deci-
sion-making for specific medical treatments or care (e.g. 
Advance Directive) regarding end of life.30 All types of ran-
domised controlled trials testing an ACP intervention for 
advanced cancer patients in any setting were included. No 
publication date was imposed. The target population was 
defined as adults (⩾18 years old) with any type of cancer 
who were in the last 12 months of their life. Studies were 
included if cancer patients formed the majority (⩾50%) of 
participants.4 Studies were excluded that focused exclu-
sively on interventions for promoting ACP completion 
rates or reported non-primary data.
Study selection
C.L. scanned all articles by title and abstract, and any with 
ambiguity as to whether with respect to inclusion/exclu-
sion criteria were retained for full-text review. Discussion 
to establish consensus with three other authors (R.H., C.E. 
and J.K.) resolved any disagreements. Endnote31 biblio-
graphic software version X8 was used to manage refer-
ences and remove duplicates.
Data extraction and management
Two data extraction sheets were developed based on 
Template for Intervention Description and Replication 
(TIDieR)22 and the Cochrane Consumers and Communi-
cation Review Group’s Data Extraction Template.32 Data 
were extracted by C.L. and checked by J.K. Two authors of 
included randomised controlled trials were contacted for 
further information. Extracted data items included setting 
(country, study setting), study design (pilot randomised 
controlled trials, parallel-group randomised controlled tri-
als, cluster randomised controlled trials and number of par-
ticipants), participant characteristics (age, sex, ethnicity, 
cancer type and education level), interventions (compo-
nents and processes, underpinning conceptual models 
and mechanisms of action) and outcomes and measure-
ment tools used. If information regarding underpinning 
conceptual models and mechanisms of action were not 
detailed in the included studies, then we extracted data 
from the supporting references cited in the included stud-
ies for further information. In the case of disagreement, 
discussion with R.H. and C.E. aimed to achieve consensus.
Assessment of risk of bias
Randomised controlled trials were critically graded by 
applying the tool for assessing risk of bias for randomised 
controlled trials proposed by Cochrane, which includes 
assessment of random sequence generation, allocation 
concealment, blinding (of patients, healthcare providers 
and outcome assessors), incomplete outcome data and 
selective reporting.23 C.L. assessed all studies and 50% 
was randomly selected and checked independently by J.K. 
Any disagreement was resolved by discussion and consen-
sus with R.H. and C.E. Review Manager (RevMan) Version 
5.3 software33 was used to manage and summarise the 
risk of bias assessment for all included randomised con-
trolled trials.
Synthesis of results
Data synthesis consisted of two parts: (1) narrative 
analysis24 and (2) intervention synthesis.34
First, a narrative synthesis was conducted following 
Guidance on the Conduct of Narrative Synthesis in 
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Systematic Review.24 A preliminary synthesis of extracted 
data was performed by textual description, tabulation, 
grouping and clustering in order to demonstrate the char-
acteristics of each included paper. Variability of context, 
study design, population, conceptual models, mecha-
nisms of action, outcomes and outcome measures were 
examined to explore the relationships within and between 
randomised controlled trials. An assessment of robust-
ness and risk of bias was conducted to appraise the qual-
ity of the evidence (see Assessment of risk of bias for 
detail). Meta-analysis was considered to examine inter-
vention sub-groups and linkage with the respective out-
comes if appropriate.
Second, an intervention synthesis was undertaken by 
summarising the processes of implementing ACP, the 
components, underpinning conceptual models and mech-
anisms of action, by applying the TIDieR checklist.22 The 
Common Components Hybrid method was used to cate-
gorise selected randomised controlled trials into different 
sub-groups according to the key processes, components 
and their characteristics.34,35
Finally, a logic model was developed following the 
Medical Research Council guidance on Process Evaluation 
of Complex Intervention21 and the Theory of Change, 
which is considered to enhance the Medical Research 
Council framework.36 The Theory of Change was used to 
describe how and why a desire behaviour change is 
expected to happen in a certain context. This aimed to 
depict how the ACP intervention was delivered, and 
mechanisms of action attributable to the intervention 
components, underpinning conceptual models and their 
linkage to intended outcomes.
Results
Study retrieval and characteristics
The search strategy retrieved 1246 records. After dupli-
cates were removed, 908 were reviewed by title and 
abstract, and 103 for full-text screening at eligibility 
stage. A total of 91 papers were excluded. The most fre-
quent reasons for exclusion were ineligible study design, 
research topic and target population (see Figure 1). In 
all, 11 papers met the eligibility criteria detailing 9 ran-
domised controlled trials including 1172 patients with 
progressive, incurable, recurrent and life-limiting 
advanced cancer (606 males and 566 females). Of two 
authors37,38 contacted for further information, one37 
provided supplementary data. All included studies were 
written in English and were from Western countries. 
The majority of randomised controlled trials were con-
ducted in North America (n = 5),38–42 seven37,39–44 were 
definitive randomised controlled trials and two of 
these applied a cluster randomised controlled trials 
design (see Table 1). More than half of the participants 
(628 patients) were highly educated (university or post-
graduate) and Caucasian.
Quality appraisal
All included randomised controlled trials adhered to a rig-
orous randomisation process by using either a computer-
generated random number table or a permuted block. 
Five randomised controlled trials adequately concealed 
allocation by using sealed envelopes,37,39,42,44,45 three ran-
domised controlled trials did not report the concealment 
method although participants blinding to the assignment 
was articulated,40,41,43 the remaining one randomised con-
trolled trial did not provide information regarding alloca-
tion concealment.38 None of the randomised controlled 
trials were able to blind intervention providers and par-
ticipants, however, five randomised controlled trials 
blinded the assessors to minimise detection bias.37,40,43–45 
Most randomised controlled trials (n = 5)38,42–45 had high 
attrition bias due to the high attrition rate (12%–55.3%). 
The common reasons for attrition were participants’ 
death,40–43,45 poor health,43–45 withdrawal40,41 or unable to 
contact the participants42,43 (see Figure 2, Table S2).
Synthesis of results
We present a logic model of ACP for people with advanced 
cancer based on the review findings (Figure 3). These 
should be read in conjunction with Tables 1 and 2.
Context
Setting. Most study sites were oncology clinics 
(n = 4).38,39,41,42 Only n = 2 randomised controlled trials40,45 
were conducted across care settings including a cancer 
centre, oncology clinic, inpatient hospital, managed care 
organisation, hospice facility and home care organisation 
(see Table 1, Figure 3).
Type of ACP. N = 3 randomised controlled trials38,39,42 
applied ACP as a written document to record patient’s 
preference for life-sustaining treatments (cardiopulmo-
nary resuscitation and mechanical ventilation); the other 
n = 6 randomised controlled trials37,40,41,43–45 considered 
ACP to be a dynamic process of discussion and decision-
making about the patients’ prognosis and end-of-life 
care15,30 (see Figure 3).
Intervention
Tools to facilitate ACP for patients and family mem-
bers. To understand the effect of different interventions, 
we categorised them as either single- or multiple-element 
interventions. Of the nine included randomised con-
trolled trials, n = 6 used single-element interventions. Of 
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Figure 1. PRISMA flow chart of study selection.
these, n = 338,39,42 adopted video decision aids simulating 
cardiopulmonary resuscitation and mechanical ventila-
tion in a clinical setting to explore a patient’s preference 
for life-sustaining treatments; the remaining n = 337,43,45 
used written information materials including question 
prompt lists, topic checklists, living wills or pamphlets on 
ACP. The question prompt list was the most commonly 
used tool in these n = 3 randomised controlled trials. In 
contrast, only n = 3 randomised controlled trials40,41,44 
adopted multiple-element interventions using at least 
two interacting tools/methods prior to the physician-
patient consultation. Of these, n = 240,41 combined written 
information materials and communication coaching as 
tools for facilitating end-of-life care discussion. The 
remaining n = 144 included all the tools/methods (video 
decision aids, written information materials and commu-
nication coaching) to boost end-of-life care discussions 
(see Figure 3, Table 1).
Sessions and duration of intervention. Most interven-
tions (n = 6) comprised only one session.37–42 For single-
element interventions (video decision aids or written 
information materials), the average duration of video 
decision aids was 4 min (range 3–6 min),38,39,42 and the 
mean time for using written information materials was 
45 min (range 30–60 min);37,43,45 In contrast, the mean 
duration of multiple-element interventions was 55 min 
(range = 45–60 min).40,41,44
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Intervention providers and training. The main providers 
of the ACP interventions were physicians (n = 3)38,40,45 and 
nurses (n = 2).44,45 Only n = 1 randomised controlled trial45 
involved members of the multidisciplinary team (e.g. phy-
sicians and nurses) to approach patients and family mem-
bers. Most randomised controlled trials (n = 5)40–42,44,45 
trained intervention providers using standardised training 
with intervention manuals,42 standardised communica-
tion coaching,40,41 clinical cancer care training,44 videos on 
physician-patient communication40 and communication 
skills training using, for example, role-play modelling45 or 
trained actors40 (see Figure 3, Table 2).
Intervention effect on intended outcomes
Video decision aids. N = 3 randomised controlled 
trials38,39,42 reported an increase in patients’ knowledge 
of cardiopulmonary resuscitation and mechanical ventila-
tion and a decrease in preference for these. However, 
n = 1 randomised controlled trial39 identified that patients’ 
uncertainty in decision-making increased after receiving 
the intervention (see Figure 3).
Written information materials. N = 2 randomised con-
trolled trials37,45 reported an increase in patients’ willing-
ness to discuss end-of-life care issues with physicians. 
Only n = 1 randomised controlled trial43 showed an inter-
vention effect of increased patients’ knowledge of cardio-
pulmonary resuscitation. There was no difference in 
patients’ depression and anxiety, satisfaction with care, 
achievement of patient information need, ACP documen-
tation rate or caregiver burden (see Figure 3).
Written information materials and communication 
coaching. N = 1 randomised controlled trial41 reported 
an increase in the discussion of end-of-life issues with 
physicians. N = 140 identified an increase in physician–
patient communication. However, there was no differ-
ence in patients’ quality of life or healthcare utilisation 
(see Figure 3).
Video decision aids, written information materials and 
communication coaching. Only n = 1 randomised con-
trolled trial44 used all three tools, reporting increases in 
discussions about end-of-life care and patients’ satisfac-
tion with care, but no difference in patients’ quality of life, 
communication self-efficacy or consultation length (see 
Figure 3).
The linkage between single/multiple-element intervention 
and outcomes. Single-element interventions37–39,42,43,45 
tended to increase patients’ knowledge about life-sustaining 
treatment, and decrease preference for these. However, 
there was no significant intervention effect on other 
patient-reported outcomes (e.g. emotional distress, satis-
faction with care) or process outcomes (e.g. ACP docu-
mentation rate); while multiple-element interventions40,41,44 
were often used to facilitate end-of-life care discussions 
between physicians and patients, and increase patients’ 
satisfaction with care. But, no significant intervention 
effect was found to increase patient’s quality of life and 
improve healthcare utilisation (see Figure 3).
Outcomes measured and measurement 
tools
Heterogeneous outcomes and tools were utilised. The 
main outcomes measured were patient-reported 
outcomes including preference for cardiopulmonary 
resuscitation,38,39,42 knowledge of life-sustaining treat-
ment (cardiopulmonary resuscitation and mechanical 
ventilation),38,39,42,43 anxiety,37,43,45 quality of life,40,44 
satisfaction with care45 and physician–patient 
communication.40,44 The majority of outcomes were 
measured by self-developed tools which lacked valida-
tion, except for anxiety (Visual Analogue Scale, 
VAS;45 Hospital Anxiety and Depression Scale, HADS;43 
Spielberger State Anxiety Inventory, SSAI37), quality of 
Figure 2. Risk of bias assessment of randomised controlled 
trials within and across studies.
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life (Function Assessment of Cancer Therapy: General, 
FACT-G;40,44 McGill Quality of Life Questionnaire, McGill 
QOL scale40,44) and physician–patient communication 
(Perceived Efficacy in Physician/Patient interaction 
Scale, PEPPI44). Completion of ACP,38,43 consulta-
tion length,37,44 place of death38,43 and intervention 
fidelity40,44 were the most frequently reported process 
outcomes (see Table1).
Figure3. Logic model of advance care planning for people with advanced cancer.
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Unintended consequences and patient 
safety
Only n = 1 randomised controlled trial45 reported adverse 
effects caused by the ACP intervention: one patient stated 
it was too morbid to continue the study, and two with-
drew for unknown reasons. N = 4 randomised controlled 
trials37–39,42 reported no adverse effects (e.g. patients’ 
emotional distress) after intervention implementation. 
However, no relevant information about adverse effects 
or patient safety was reported in the other n = 4 ran-
domised controlled trials.40,41,43,44
Underpinning conceptual models, 
mechanisms of action and the linkage to 
outcomes
Underpinning conceptual models. N = 4 randomised con-
trolled trials40,41,43,44 applied conceptual models to under-
pin the intervention (n = 3);41,43,44 study aims, intervention 
and outcome measures (n = 1)40. N = 241,44 used the Self-
Determination Theory of Health-Related Behaviour 
Change,51,52 n = 143 used the Shared Decision-Making 
Model49 and n = 140 used the Ecological Model of Patient-
Centred Communication.53 N = 3 models41,43,44 only con-
sidered individual behaviour change and the majority of 
underpinning models (n = 3)40,41,44 were identified in 
randomised controlled trials published during 2017 (see 
Figure 3).
Mechanisms of action. The mechanisms through which 
video decision aids improved outcomes were by increas-
ing patients’ knowledge in terms of illness and the bene-
fits and burdens of specific medical treatments. This 
assisted patients to imagine the disease state and its 
treatment. In addition, for people with limited health lit-
eracy or for whom English was an additional language, 
complex information about illness and medical treatment 
options could be transmitted more easily by videos than 
written materials.46 The mechanisms of action for written 
information materials aimed at facilitating end-of-life care 
discussion were via an opportunity for patients to learn 
about end-of-life issues prior to their consultations with 
physicians.47,48 This assisted them in thinking ahead and 
acquiring information that was suited to their needs and 
at their own pace.50 A consistent end-of-life care decision 
was made by the shared decision-making process between 
physicians and patients,49 and patients could maintain a 
sense of control through this process.47,48 The mecha-
nisms through which communication coaching changed 
behaviour were by increasing patients’ ‘autonomous 
motivation’ to ask questions or discuss issues about their 
end of life, improving their self-perceived sense of ‘com-
petence’ to participate in the discussion and make health-
related behavioural change. These interventions were 
intended to be conducted in a trustful clinician–patient 
relationship when patients are ready (relatedness), so 
they can maintain behaviour change over time51–53 (see 
Figure 3, Table 2).
The linkage between underpinning conceptual models and 
outcomes. Patients’ knowledge of cardiopulmonary 
resuscitation was improved by the process of information 
sharing from physician and patient, which was stressed in 
the Shared Decision-Making Model.43 According to the 
Self-Determination Theory of Health-Related Behaviour 
Change,41,44 building up the patients’ motivation and com-
petence for initiating new health-related change was the 
key factor for achieving an increase in end-of-life care dis-
cussions and patients’ satisfaction with care. Better physi-
cian–patient communication was found in the intervention 
underpinned by the Ecological Model of Patient-Centred 
Communication,40 which emphasised the mutual interac-
tion between medical staff, patients, and clinical and 
social context for better outcomes. Regardless of whether 
underpinning theory was used or not, there was no sig-
nificant intervention effect on some patient-reported out-
comes (e.g. emotional distress and quality of life) and 
process outcomes (e.g. ACP documentation rate and con-
sultation length).
Discussion
This is the first study to systematically appraise the evi-
dence to investigate underpinning conceptual models, 
ACP interventions, mechanisms of action and intended 
outcomes of ACP for patients with cancer. A novel logic 
model was developed to better understand the context 
and problem, and linkage between active ingredients and 
the intended outcomes. Moreover, we found that the 
development of the ACP interventions was poorly 
reported, and the literature is heavily focused on Western 
highly educated Caucasian patients. This limits generalis-
ability to other cultures. Conceptual models were used to 
inform the trial designs, but their use was uncommon. 
When used, they focused mainly on individual behaviour 
change. Only one trial used an organisational approach. 
This type of organisational approach is important to 
implement and realise the benefit of a complex interven-
tion as it works on multiple interacting levels.21 If we little 
consider the organisational level of change, and only con-
sider the individual, then it is unlikely to sustain the 
change. Therefore, an approach targeting multiple levels 
in a whole-systems approach should be encouraged for 
continuous change and impact on patients, families and 
healthcare system.17 Finally, the logic model is based on 
current best available evidence, which we have dem-
onstrated to have a Western basis. Therefore, the cultural 
appropriateness of this newly developed logic model of 
ACP interventions should be assessed prior to 
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implementation in non-Western cultures to enhance 
intervention uptake and effectiveness.
The logic model
This novel logic model presents key elements for ACP 
implementation. A noteworthy effect was increasing 
patients’ knowledge of life-sustaining treatments and 
decreasing their preference for these by using video deci-
sion aids was found.54 But there was no significant inter-
vention effect on several patient-reported outcomes (e.g. 
anxiety, depression and quality of life) and process out-
comes (e.g. ACP completion rate, consultation length and 
healthcare utilisation) by using written information mate-
rials and communication coaching, they did facilitate early 
end-of-life care discussion. These findings are dissimilar to 
findings from previous reviews on the effectiveness of 
ACP (e.g. ACP could potentially reduce patients’ and rela-
tives’ emotional distress, increase the ACP documenta-
tion and palliative care utilisation8,10,55). This appears to 
relate to factors of heterogeneity in the target population 
(cancer and non-cancer), limitation of theory used and 
bias in trial design (e.g. underpowered). Only four trials 
were identified that explicitly used conceptual models to 
underpin the intervention development and only two 
cited separate publications articulating the development 
work that informed the ACP intervention. This indicated 
the lack of conceptual models usage when developing 
complex interventions, which might compromise the 
quality of research work as the effectiveness could not be 
promised.56 It is notable that a trend for applying concep-
tual models for study design was found over time (three 
trials applying theoretical underpinning were published 
during 2017). This shows a recent increase in incorporat-
ing theoretical underpinnings into interventions to max-
imise the effectiveness aligned to methodological 
guidance.56 However, use of theoretical underpinning in 
trials on ACP for advanced cancer patients and demon-
stration of effectiveness on the main outcome is equivo-
cal. This might be explained by the complex nature of the 
components and mechanisms of action of the ACP pro-
cess that came across strongly in our synthesis.
Active ingredients in mechanisms of action
It may be hard to judge the superiority of one ACP inter-
vention over another due to the heterogeneity of inter-
ventions and outcome measures used. But it is potentially 
possible to identify the active ingredients of ACP mecha-
nisms to inform an implementation model. Clinicians 
should focus on these active ingredients to support the 
delivery of ACP in practice. The mechanisms of action we 
identified in this review extended existing understanding. 
Increasing death literacy among patients and family 
members is deemed to facilitate ACP discussion.57 In this 
review, an increase in patient’s understanding of life-sus-
taining treatment, and willingness of participating in end-
of-life care discussion were found by providing informative 
materials such as video decision aids and information 
sheets. However, there was scant evidence reporting the 
subsequent increase of ACP documentation to guide clini-
cal practice in accordance with patient’s wishes, leading 
to better healthcare outcomes.10 Therefore, measuring 
ACP documentation use is suggested in further study on 
people with advanced cancer to examine the association 
with end-of-life discussion. ‘Autonomous motivation’, 
‘competence’ and ‘relatedness’ were highlighted as mech-
anisms for individual (patient) behaviour change in Self-
Determination Theory of Health-Related Behaviour 
Change,51 and found to improve the patients’ satisfaction 
with care at the end of life. A communication coaching 
programme for patients was recognised as the key inter-
vention along with the informative materials to improve 
patients’ satisfaction with care. This highlighted the 
importance of actively educating patients prior to the reg-
ular oncology consultation to enhance their ‘motivation’ 
and ‘competence’ to take part in an ACP discussion rather 
than just providing information on ACP to them. This 
should occur in a trustful relationship between them and 
clinicians at patients’ pace (‘relatedness’). Most impor-
tantly, a supportive contextual environment (e.g. availa-
bility of administrative system, sufficient resources, policy 
convictions and cultural acceptance) should be in place to 
support the implementation.17 In addition, communica-
tion and coaching skills training for medical staff were 
identified as essential requirements for successful ACP 
implementation. This echoed the importance of adopting 
an organisational level theory such as Ecological Model of 
Patient-Centred Communication53 to develop an ACP 
intervention with optimal effectiveness. Our logic model 
therefore highlights the importance of applying a broader 
theory focusing on organisational change, addressing 
mutual interactions between patients, families and clini-
cians, as well as the clinical and social context. This ena-
bles patients’ ongoing participation in end-of-life care 
discussions and assists them to participate in decisions to 
improve outcomes over time.53
Details of ACP intervention
Details on intervention development were poorly reported 
and often lacking, making it difficult to understand the 
thoroughness of the components, conceptual frameworks, 
the mechanism of action and even patient safety informa-
tion, which are all crucial for developing a feasible and 
effective intervention.34,58 A previous review investigating 
the descriptions of treatment in trials and reviews 
showed that only 50% of included studies could be rep-
licated by healthcare professionals or researchers.59 The 
limited detail on the interventions and their underpinning 
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conceptual models might hinder replication and transla-
tion by clinicians or other researchers both in clinical prac-
tice and research, and compromise the effectiveness of 
interventions. In line with the Medical Research 
Council guidance on Process Evaluation of Complex 
Interventions21 and TIDieR guideline,22 we suggest authors 
provide greater detailed information about the develop-
ment and evaluation of interventions. In particular, it is 
important to identify causality and the mechanisms of 
action between each component and process of the inter-
vention, so it can be translated to different cultures.
Cultural acceptability and transferability
Studies reporting the components, processes and 
underpinning conceptual frameworks of ACP are lim-
ited to Western countries. We identified that all the 
included randomised controlled trials were conducted 
in Western countries and mainly in North America, 
Australia and the United Kingdom. This reflects estab-
lished legislation on facilitating patients’ right to self-
determination in medical care decisions in these 
countries (e.g. Self-Determination Act in North 
America,60 Mental Capacity Act 2005 in England and 
Wales61 and Statute Law and Common Law in 
Australia62). In Eastern countries such as Taiwan, legis-
lation to facilitate patient’s autonomy (Patient 
Autonomy Act63) was recently passed and, conse-
quently, ACP is a relatively new concept. The cultural 
acceptability and transferability of this Western-
oriented ACP logic model in different cultures are 
unknown. Studies evaluating ACP in non-Western coun-
tries have recruited from the non-cancer population 
(e.g. Chan and colleague’s work on nursing-home resi-
dents in Hong Kong64 and Stanford et al.’s20 work on 
professional groups including teachers, hospice staff 
and pastors in South Africa). This indicates the develop-
ment and evaluation of ACP in other cultures, focused 
on older people with non-malignant conditions and 
healthy public. Subsequent experimental empirical 
studies are required among these populations.
Strengths and limitations
The strength of this review is that it is the first to clarify 
the components, processes, conceptual models and 
mechanisms of action underpinning ACP. From this, a 
novel logic model has been developed to inform the key 
information and characteristics for practice, further 
research and most importantly, translating ACP into other 
cultures. By analysing the components and conceptual 
models separately, we are able to determine the dynamic 
mechanism between interventions and outcomes. The 
findings are also strengthened by a comprehensive lit-
erature search including electronic databases and 
hand-searching, and adherence to many guidelines and 
methods. However, our review has several limitations. A 
meta-analysis was not appropriate to examine the pooled 
intervention effect due to the small number of partici-
pants in each sub-group (single or multiple-element inter-
ventions) and the heterogeneous nature of included 
interventions.65 Furthermore, the high attrition rate in the 
selected studies reduced statistical power, although this is 
expected in palliative care trials and research with 
advanced cancer patients.66 Finally, this logic model may 
not be generalised to other disease conditions, and it 
might be worth looking at how ACP for other patient 
groups might be adaptable to the cancer population 
(e.g. Respecting Choices67 or Physician Orders for Life-
Sustaining Treatment68).
Conclusion
A novel logic model, illustrating how the components and 
processes of ACP operate, has been constructed, using 
robust trial evidence. The use of conceptual frameworks 
to underpin ACP is uncommon. When used, the frame-
works mainly focus on individual behavioural change, 
rather than considering a wider organisational approach. 
Key mechanisms of action were focused on facilitating 
patient’s knowledge, and building up motivation and 
competence in participating ACP, then making a decision 
in a trustful clinician–patient relationship. Single-element 
intervention improved patients’ understanding of life-
sustaining treatments and reduced their preference for 
these at the end of life. Multiple-element intervention 
facilitated end-of-life discussions in subsequent consulta-
tions. This logic model cannot be currently transferred as 
the theory is not underpinned enough and it is mainly 
Western oriented, leading to a major obstacle to good 
care globally. There is also an urgent requirement to 
explore applicability of this Western-oriented logic model 
for different educational levels and ethnicities in non-
Western countries, aiming to improve the access of pal-
liative care worldwide so as to meet the Universal Health 
Coverage goals.69
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